Stillwater, OK, United States of America

Chun-Lin Chen

This inventor holds 2 USPTO granted patents. Top assignee: Oklahoma State University. Active years: 1995-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chun-Lin Chen. Retrieved from https://idiyas.com/inventor/chun-lin-chen-ya8aen4v

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 2

Forward Citations = 38(Granted Patents)


Company Filing History:


Years Active: 1995-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Chun-Lin Chen

Introduction

Chun-Lin Chen is a notable inventor based in Stillwater, OK (US). He has made significant contributions to the field of antiarrhythmic agents, holding a total of 2 patents. His work focuses on the development of novel compounds that have the potential to improve medical treatments.

Latest Patents

Chun-Lin Chen's latest patents include N-alkyl and N-acyl derivatives of 3,7-Diazabicyclo-[3.3.1]nonanes. These compounds are disclosed as multiclass antiarrhythmic agents. The general formula for these derivatives includes specific configurations where Q=S, Z=CH₂, and Y represents an N-acyl or N-alkyl group. His research aims to provide new solutions for managing arrhythmias effectively.

Career Highlights

Chun-Lin Chen is affiliated with Oklahoma State University, where he continues to advance his research and innovation in the field of pharmacology. His academic background and ongoing projects contribute to the university's reputation as a center for cutting-edge research.

Collaborations

Chun-Lin Chen has collaborated with notable colleagues such as Kenneth D Berlin and Gregory Lynn Garrison. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Chun-Lin Chen's work exemplifies the spirit of innovation in the medical field. His contributions through patents and collaborations are paving the way for advancements in antiarrhythmic treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…